The Expressions of Asprosin and CTRP3 in Serum of Patients with Polycystic Ovary Syndrome and Their Clinical Significances

The Expressions of Asprosin and CTRP3 in Serum of Patients with Polycystic Ovary Syndrome and Their Clinical Significances

LIU Yao

PDF(1002 KB)

Welcome to Labeled Immunoassays and Clinical Medicine website! Share:

PDF(1002 KB)

Labeled Immunoassays and Clinical Medicine ›› 2022, Vol. 29 ›› Issue (1) : 85-89. DOI: 10.11748/bjmy.issn.1006-1703.2022.01.018

Clinical Investigation

The Expressions of Asprosin and CTRP3 in Serum of Patients with Polycystic Ovary Syndrome and Their Clinical Significances

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 29(1): 85-89 https://doi.org/10.11748/bjmy.issn.1006-1703.2022.01.018

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(1002 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉